Zobrazeno 1 - 10
of 48
pro vyhledávání: '"I, Dalifard"'
Autor:
J. Wafflart, J. P. Basuyau, H. Larbre, I. Dalifard, G. Ricolleau, F. Bonnetain, M. F. Pichon, N. Eche, Jean-Marc Riedinger
Publikováno v:
Annals of Oncology. 18:881-885
CA 125 assays enable treatment response monitoring in ovarian cancer.This multicentric study was carried out to assess the prognostic value of the CA 125 change after the first and the second courses of induction chemotherapy (CT). Of the 494 stage I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1b45bf383f540af5cabf05310298ac0
https://doi.org/10.1093/annonc/mdl500
https://doi.org/10.1093/annonc/mdl500
Autor:
J. Wafflart, Jean-Marc Riedinger, G. Ricolleau, K. Hacene, N. Eche, I. Dalifard, J. P. Basuyau, H. Larbre, M. F. Pichon, C. Touzery
Publikováno v:
Oncologie. 8:132-138
Cette etude multicentrique de la cinetique de CA-125 sous chimiotherapie d’induction a ete realisee sur une population de 631 patientes porteuses d’un cancer ovarien epithelial (stade FIGOI a IV). Le recul median (extremes) est de37 mois (2-222 m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e61a80a8c43ce580dfe04d193e4e4780
https://doi.org/10.1007/s10269-006-0348-8
https://doi.org/10.1007/s10269-006-0348-8
Publikováno v:
Gynecologic oncology. 109(2)
Background CA 125 assays enable treatment–response monitoring in ovarian cancer. Methods A multicentric study of CA 125 kinetics under paclitaxel/platinum-based chemotherapy was performed in 130 stage IIc–IV patients. CA 125 half-life and nadir c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f357f2be998924f77f5f4342b969d9ad
https://pubmed.ncbi.nlm.nih.gov/18329083
https://pubmed.ncbi.nlm.nih.gov/18329083
Autor:
J. Wafflart, H. Larbre, J. P. Basuyau, Jean-Marc Riedinger, N. Eche, K. Hacene, M. F. Pichon, I. Dalifard, G. Ricolleau
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 17(8)
Background: CA 125 assays enable treatment-response monitoring in ovarian cancer. Patients and methods: A multicentric study of CA 125 kinetics under induction chemotherapy was performed in 631 patients. CA 125 half-life was calculated by mono-compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d9b0c53371498988e750ea3156b553b
https://pubmed.ncbi.nlm.nih.gov/16766592
https://pubmed.ncbi.nlm.nih.gov/16766592
Publikováno v:
Anticancer research. 19(6B)
Mutations of the TP53 gene induce the production of an abnormal protein (p53) with a prolonged half-life allowing its detection by monoclonal antibodies and leading to a development of serum p53 autoantibodies. We have quantified the protein p53 in 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1c76b9091356c37f24a757408cce03f6
https://pubmed.ncbi.nlm.nih.gov/10697504
https://pubmed.ncbi.nlm.nih.gov/10697504
Publikováno v:
International Journal of Molecular Medicine.
In breast cancer, DNA amplification of the oncogene c-erbB-2, encoding for the p185 protein, is associated with a poor prognosis. A retrospective study on a population of 220 cases of primary breast cancer permitted a quantitative measure of p185 onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d86afe709be0487cf0443a0d3d2f9221
https://doi.org/10.3892/ijmm.1.5.855
https://doi.org/10.3892/ijmm.1.5.855
Autor:
G, Besse, F, Kwiatkowski, G, Gaillard, A, Daver, I, Dalifard, J P, Basuyau, P, Brunelle, J, Wafflart, R M, Angibeau, E, Auvray
Publikováno v:
Bulletin du cancer. 81(4)
pS2 protein assay was performed with Elsa-pS2 kit (CIS-Biointernational) on a group of 1,065 patients with operable breast cancer who underwent breast surgery in the years 1982 through 1990. The median follow-up was 57 months. This group included exc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c198cc672ffb5f976f646445702811b
https://pubmed.ncbi.nlm.nih.gov/7703545
https://pubmed.ncbi.nlm.nih.gov/7703545
Autor:
A, Daver, I, Dalifard, D, Pons-Anicet, B P, Krebs, P, Gosselin, J L, Cazin, G, Ricolleau, G, Gaillard, F, Gachon, J, Goussard
Publikováno v:
Bulletin du cancer. 77(8)
A multicenter and retrospective study of the diagnosis value of SCC-TA4 in squamous cell carcinomas of 4 localisations was made with the 2 thresholds of 2 and 2.5 ng/ml. However, 3.1% of controls have a SCC value above 2.5 ng/ml. Sixteen benign gynec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8c96f1d3533215731cca38f3dcd0d73
https://pubmed.ncbi.nlm.nih.gov/2207367
https://pubmed.ncbi.nlm.nih.gov/2207367
Autor:
P G, Bocquillon, A, Daver, M, Page, I, Dalifard, A, Chassevent, P, Cellier, G, Bertrand, F, Larra, P, George, B, Chabrun
Publikováno v:
Bulletin du cancer. 76(3)
We report a flow cytometric study on ploidy in 117 colorectal cancers. An aneuploid cell population was found in more than 70% of adenocarcinomas. Ploidy was found to be stage-related; aneuploid tumors with DNA index greater than or equal to 1.4 were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17abb3c853e565d48df582437787b144
https://pubmed.ncbi.nlm.nih.gov/2736315
https://pubmed.ncbi.nlm.nih.gov/2736315
Publikováno v:
Anticancer research. 6(5)
Carcinoembryonic antigen was measured in serum and in extracts from 37 colorectal tumors and we found a poor correlation between circulating and tumor CEA. Monoclonal antiCEA antibodies were used in indirect immunoperoxidase staining of the correspon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a9e5abc65d6264d17cfd5def6223a329
https://pubmed.ncbi.nlm.nih.gov/3541780
https://pubmed.ncbi.nlm.nih.gov/3541780